Go to page content

Research Week: Antibiotic Resistance Up Close — A Structural Biologist View on a Global Health Threat

Wednesday, Nov. 23, 1-2 p.m.

CSF-1302

2022 Brosnan Lecture in Biochemistry

Presented by Dr. Albert Berghuis
Department of Biochemistry, Faculty of Medicine and Health Sciences
McGill University

The dangers antibiotic resistance poses to human health needs little introduction. Statistics, such as that already over one million deaths annually are directly attributable to resistant bacteria, have been well publicized.

The WHO has advocated a multi-pronged approach to address this global health threat, which includes developing new medicines. Dr. Berghuis’s lab uses structural biological approaches to examine various mechanisms of antibiotic resistance, with the objective of informing the development of new therapeutic options for treating bacterial infections.

Notably, they have examined enzyme-mediated resistance to aminoglycoside and macrolide antibiotics. Their findings have underscored the difficulties of drug development in the context of widespread multi-drug resistance, but have also revealed viable avenues to combat resistance.

This is a Research Week 2022 event

Presented by Department of Biochemistry, Faculty of Science

Event Listing 2022-11-23 13:00:00 2022-11-23 14:00:00 America/St_Johns Research Week: Antibiotic Resistance Up Close — A Structural Biologist View on a Global Health Threat 2022 Brosnan Lecture in Biochemistry Presented by Dr. Albert Berghuis Department of Biochemistry, Faculty of Medicine and Health Sciences McGill University The dangers antibiotic resistance poses to human health needs little introduction. Statistics, such as that already over one million deaths annually are directly attributable to resistant bacteria, have been well publicized. The WHO has advocated a multi-pronged approach to address this global health threat, which includes developing new medicines. Dr. Berghuis’s lab uses structural biological approaches to examine various mechanisms of antibiotic resistance, with the objective of informing the development of new therapeutic options for treating bacterial infections. Notably, they have examined enzyme-mediated resistance to aminoglycoside and macrolide antibiotics. Their findings have underscored the difficulties of drug development in the context of widespread multi-drug resistance, but have also revealed viable avenues to combat resistance. This is a Research Week 2022 event CSF-1302 Department of Biochemistry, Faculty of Science